BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21160718)

  • 1. Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.
    Wong GL; Xu HX; Xie XY
    World J Radiol; 2009 Dec; 1(1):25-36. PubMed ID: 21160718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study.
    de Sio I; Iadevaia MD; Vitale LM; Niosi M; Del Prete A; de Sio C; Romano L; Funaro A; Meucci R; Federico A; Loguercio C; Romano M
    United European Gastroenterol J; 2014 Aug; 2(4):279-87. PubMed ID: 25083285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
    Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients.
    Wu W; Chen M; Yan K; Dai Y; Yin S; Yang W; Fan Z
    Chin J Cancer Res; 2015 Feb; 27(1):83-9. PubMed ID: 25717230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal liver lesions in cirrhosis: Role of contrast-enhanced ultrasonography.
    Bartolotta TV; Randazzo A; Bruno E; Taibbi A
    World J Radiol; 2022 Apr; 14(4):70-81. PubMed ID: 35646291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases.
    Saito A; Yamamoto M; Katagiri S; Yamashita S; Nakano M; Morizane T
    Glob Health Med; 2020 Oct; 2(5):319-327. PubMed ID: 33330827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
    Sawatzki M; Meyenberger C; Brand S; Semela D
    Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
    Kim TK; Lee KH; Khalili K; Jang HJ
    Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Contrast-Enhanced Ultrasound in the Differentiation between Hepatocellular Carcinoma and Benign Liver Lesions.
    Dobek A; Kobierecki M; Ciesielski W; Grząsiak O; Fabisiak A; Stefańczyk L
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tips and Tricks in Contrast-Enhanced Ultrasound (CEUS) for the Characterization and Detection of Liver Malignancies.
    Schellhaas B; Strobel D
    Ultraschall Med; 2019 Aug; 40(4):404-424. PubMed ID: 31382313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
    Quaia E
    Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study.
    Dong Y; Wang WP; Lee WJ; Meloni MF; Clevert DA; Chammas MC; Tannapfel A; Forgione A; Piscaglia F; Dietrich CF
    Ultrasound Med Biol; 2022 Sep; 48(9):1797-1805. PubMed ID: 35710501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound.
    Chen S; Qiu YJ; Zuo D; Shi SN; Wang WP; Dong Y
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36291962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm).
    Mei Q; Yu M; Chen Q
    World J Clin Cases; 2022 Aug; 10(24):8525-8534. PubMed ID: 36157793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization of focal liver lesions using an innovative contrast-enhanced ultrasound technique].
    Xu HX; Liu GJ; Lü MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1375-8. PubMed ID: 16318772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma.
    Moudgil S; Kalra N; Prabhakar N; Dhiman RK; Behera A; Chawla YK; Khandelwal N
    J Clin Exp Hepatol; 2017 Sep; 7(3):222-229. PubMed ID: 28970709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.